We are live on ! Find out more
BNGO icon

Bionano Genomics
BNGO

143 hedge funds and large institutions have $114M invested in Bionano Genomics in 2022 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 37 increasing their positions, 42 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

77% more call options, than puts

Call options by funds: $2.82M | Put options by funds: $1.59M

0.01% more ownership

Funds ownership: 0.04% → 0.05% (+0.01%)

0% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 18

3% less funds holding

Funds holding: 148 → 143 (-5)

12% less repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 42

39% less capital invested

Capital invested by funds: $187M → $114M (-$73.7M)

Holders
143
Holders Change
-5
Holders Change %
-3.38%
% of All Funds
2.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
37
Reduced
42
Closed
18
Calls
$2.82M
Puts
$1.59M
Net Calls
+$1.22M
Net Calls Change
-$552K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$6.09M
2
BlackRock
BlackRock
New York
+$4.16M
3
Citadel Advisors
Citadel Advisors
Florida
+$2.12M
4
Mirae Asset Global Investments
Mirae Asset Global Investments
South Korea
+$2.07M
5
Morgan Stanley
Morgan Stanley
New York
+$1.7M

Top Sellers

Rank Fund Capital Flow
1
Principal Financial Group
Principal Financial Group
Iowa
-$1.07M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$701K
3
Jane Street
Jane Street
New York
-$658K
4
Millennium Management
Millennium Management
New York
-$620K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$415K
Name Holding Trade Value Shares
Change 		Change in
Stake
AWM
126
AllSquare Wealth Management
New York
$3K – – –
TWA
127
TCI Wealth Advisors
Arizona
$3K – – –
AIP
128
Ahrens Investment Partners
Louisiana
$2K – – –
CAPTRUST Financial Advisors
129
CAPTRUST Financial Advisors
North Carolina
$2K – – –
KIG
130
Kessler Investment Group
Indiana
$2K – – –
Federated Hermes
131
Federated Hermes
Pennsylvania
$2K +$1.03K +1 New
GEA
132
Glen Eagle Advisors
New Jersey
$1.15K – – –
AF
133
Allworth Financial
California
$1K – – –
AA
134
Ancora Advisors
Ohio
$1K – – –
Fifth Third Bancorp
135
Fifth Third Bancorp
Ohio
$1K – – –
GRP
136
Global Retirement Partners
California
$1K – – –
National Bank of Canada
137
National Bank of Canada
Quebec, Canada
$1K – – –
Northwestern Mutual Wealth Management
138
Northwestern Mutual Wealth Management
Wisconsin
$1K – – –
PNC Financial Services Group
139
PNC Financial Services Group
Pennsylvania
$1K – – –
TF
140
TimeScale Financial
Massachusetts
$1K – – –
CWM
141
Castle Wealth Management
Florida
$1K +$2.06K +2 New
Bank of Montreal
142
Bank of Montreal
Ontario, Canada
$93 +$6.17K +6 +6%
WWP
143
WR Wealth Planners
Missouri
$1 – – –
Millennium Management
144
Millennium Management
New York
– -$620K -400 Closed
Allspring Global Investments
145
Allspring Global Investments
North Carolina
– -$253K -164 Closed
Handelsbanken Fonder
146
Handelsbanken Fonder
Sweden
– -$136K -88 Closed
BCM
147
Bayesian Capital Management
New York
– -$132K -85 Closed
EVM
148
Eaton Vance Management
Massachusetts
– -$129K -83 Closed
CI
149
CPR Investments
Michigan
– -$77K -49 Closed
HF
150
HRT Financial
New York
– -$70K -46 Closed
3 4 5
6
7

BNGO Hedge Fund Activity: Q2 2022 in Review

143 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q2 2022, worth a combined $114M — down 39% from $187M a quarter earlier.

Fund positioning in BNGO was balanced in Q2 2022: 18 funds opened new positions, 18 closed out, 37 added to existing stakes and 42 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $6.09M. The largest seller was Principal Financial Group, cutting an estimated $1.07M.

  • 143 institutional investors held Bionano Genomics (BNGO) as of Q2 2022, down from 148 in Q1 2022.
  • Funds reported $114M of Bionano Genomics stock for Q2 2022, down 39% quarter-over-quarter.
  • 18 funds opened new Bionano Genomics positions in Q2 2022 and 18 closed out, a net change of 0 holders.
  • The largest Bionano Genomics buyer in Q2 2022 was Renaissance Technologies, an estimated $6.09M added.
  • The largest Bionano Genomics seller in Q2 2022 was Principal Financial Group, an estimated $1.07M sold.

Based on aggregated 13F filings for Q2 2022.